oisol - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

1509-35-9

D-别异亮氨酸;
(2R,3S)-2-氨基-3-甲基戊酸

D-Alloisoleucine;
(2R,3S)-2-Amino-3-methylpentanoic acid

(S)-3-甲基-2-氧代戊酸钙盐

Calcium (S)-3-methyl-2-oxovalerate;
Calcium alpha-ketoisoleucine (1:2)

Fmoc-L-beta-高异亮氨酸;
N-芴甲氧羰基-L-beta-高异亮氨酸

Fmoc-L-beta-homoisoleucine;
(3R,4S)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methylhexanoic acid

Boc-L-beta-高异亮氨酸;
N-叔丁氧羰基-L-beta-高异亮氨酸

Boc-L-beta-homoisoleucine;
Boc-beta-Homoile-OH;
(3R,4S)-3-(Boc-amino)-4-methylhexanoic acid

L-beta-高异亮氨酸盐酸盐

L-beta-Homoisoleucine hydrochloride;
(3R,4R)-3-Amino-4-methylhexanoic acid hydrochloride

DL-别异亮氨酸

Alloisoleucine;
Alloisoleucine,DL- (8CI);
(?à)-allo-Isoleucine;
DL-Alloisoleucine;
DL-allo-Isoleucine

Alloisoleucine,2-methyl- (9CI);
Alloisoleucine, 2-methyl- (9CI)

Actinomycin D,2-deamino-2A-D-alloisoleucine-2B-D-alloisoleucine- (9CI);
ActinomycinC3, deamino- (8CI);
1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine,cyclic peptide deriv.;
3H-Phenoxazine, actinomycin D deriv.;
DeaminoactinomycinC3

Actinomycin E2 (9CI);
ActinomycinD,2A-D-alloisoleucine-2B-D-alloisoleucine-5A-(N-methylisoleucine)-5B-(N-methylisoleucine)-;
1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine, cyclic peptidederiv.;
3H-Phenoxazine, actinomycin D deriv.;
3H-Phenoxazine-1,9-dicarboxamide,2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-

Alloisoleucine,N-acetyl- (9CI);
DL-Alloisoleucine,N-acetyl-;
N-Acetyl-DL-alloisoleucine;
NSC 203442

Actinomycin C2a(8CI,9CI);
ActinomycinD, 2B-D-alloisoleucine-;
1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine, cyclic peptidederiv.;
3H-Phenoxazine, cyclic peptide deriv.;
3H-Phenoxazine-1,9-dicarboxamide,2-amino-N1-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N9-[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(1-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-;
Actinomycin Ay2

Actinomycin Au6b(8CI,9CI);
ActinomycinD,2A-D-alloisoleucine-2B-D-leucine-5A-(N-methyl-D-valine)-5B-(N-methyl-D-valine)-;
1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine, actinomycin D deriv.;
3H-Phenoxazine, actinomycin D deriv.;
3H-Phenoxazine-1,9-dicarboxamide,2-amino-N1-[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(1-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N9-[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(2-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-;
Actinomycin Au6(I)

Actinomycin F3 (9CI);
ActinomycinD,2A-D-alloisoleucine-2B-D-alloisoleucine-3A-(N-methylglycine)-3B-(N-methylglycine)-;
1-Oxa-4,7,10,13-tetraazacyclohexadecane, cyclic peptide deriv.;
3H-Phenoxazine,actinomycin D deriv.;
3H-Phenoxazine-1,9-dicarboxamide,2-amino-4,6-dimethyl-3-oxo-N,N'-bis[4,7,10,16-tetramethyl-3-(1-methylethyl)-12-(1-methylpropyl)-2,5,8,11,14-pentaoxo-1-oxa-4,7,10,13-tetraazacyclohexadec-15-yl]-

Aureobasidin T3 (9CI);
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-L-phenylalanyl-b-hydroxy-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, N-[N-[N-[N-[1-[b-hydroxy-N-[N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, (R)-

Actinomycin C3(6CI,7CI,8CI,9CI);
ActinomycinD, 2A-D-alloisoleucine-2B-D-alloisoleucine-;
1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine,actinomycin D deriv.;
3H-Phenoxazine, actinomycin D deriv.;
3H-Phenoxazine-1,9-dicarboxamide,2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(1-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-;
Actinomycin Ay1

Actinomycin D,2A-D-alloisoleucine-;
ActinomycinC2 (6CI,7CI,8CI,9CI);
1H-Pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecine,cyclic peptide deriv.;
3H-Phenoxazine, actinomycin D deriv.;
3H-Phenoxazine-1,9-dicarboxamide,2-amino-N9-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-N1-[hexadecahydro-2,5,9-trimethyl-6-(1-methylethyl)-13-(1-methylpropyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-;
NSC 87221

Cyclo[L-alanyl-D-alloisoleucyl-(3S,4S)-3-hydroxy-4-methyloctanoyl-L-phenylalanyl];
BeauveriolideIII;
FO 6979

N-芴甲氧羰基-D-别异亮氨酸

D-Alloisoleucine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;
N-[(9H-Fluoren-9-yl)methoxycarbonyl]-D-alloisoleucine

Boc-D-造血岛羟基

D-Alloisoleucine,N-[(1,1-dimethylethoxy)carbonyl]-;
N-tert-Butoxycarbonyl-D-alloisoleucine

D-Leucine,(2S)-2-hydroxy-3-methylbutanoyl-D-alloisoleucyl- (9CI);
D-Leucine,N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-D-alloisoleucyl]-, (S)-;
Leucine,N-[N-(L-2-hydroxy-3-methylbutyryl)-D-alloisoleucyl]- (7CI);
Leucine,N-[N-(L-2-hydroxy-3-methylbutyryl)-D-alloisoleucyl]-, D- (8CI);
Sporidesmolicacid D

C17H32N2O5

详情

供应商

化工产品